Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$24.03 - $27.02 $1.07 Million - $1.21 Million
-44,700 Reduced 71.22%
18,064 $487,000
Q3 2022

Nov 14, 2022

BUY
$11.6 - $20.44 $213,938 - $376,974
18,443 Added 41.61%
62,764 $1.13 Million
Q3 2022

Nov 14, 2022

BUY
$11.6 - $20.44 $213,938 - $376,974
18,443 Added 41.61%
62,764 $1.13 Million
Q2 2022

Aug 16, 2022

SELL
$7.78 - $14.69 $47,271 - $89,256
-6,076 Reduced 12.06%
44,321 $551,000
Q1 2022

May 17, 2022

SELL
$11.38 - $16.4 $105,560 - $152,126
-9,276 Reduced 15.54%
50,397 $672,000
Q4 2021

Feb 15, 2022

BUY
$14.31 - $23.87 $351,897 - $586,987
24,591 Added 70.1%
59,673 $929,000
Q3 2021

Nov 16, 2021

SELL
$18.94 - $26.99 $610,076 - $869,374
-32,211 Reduced 47.87%
35,082 $788,000
Q2 2021

Aug 16, 2021

BUY
$17.07 - $24.56 $62,100 - $89,349
3,638 Added 5.72%
67,293 $1.53 Million
Q1 2021

May 18, 2021

BUY
$20.46 - $25.18 $980,340 - $1.21 Million
47,915 Added 304.42%
63,655 $1.31 Million
Q4 2020

Feb 17, 2021

SELL
$13.8 - $27.62 $983,705 - $1.97 Million
-71,283 Reduced 81.91%
15,740 $435,000
Q3 2020

Nov 17, 2020

BUY
$14.05 - $22.6 $1.22 Million - $1.97 Million
87,023 New
87,023 $1.22 Million
Q1 2020

May 15, 2020

SELL
$6.55 - $14.76 $158,149 - $356,380
-24,145 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.2 - $19.21 $101,409 - $463,825
24,145 New
24,145 $374,000

Others Institutions Holding MYOV

About Myovant Sciences Ltd.


  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.